dengu
preval
viral
diseas
world
caus
four
close
relat
antigen
distinct
serotyp
dengu
viru
genu
flaviviru
famili
flavivirida
recent
map
dengu
risk
basi
global
popul
estim
million
infect
worldwid
million
manifest
appar
bhatt
et
al
estim
three
time
higher
predict
burden
particular
brazil
report
largest
number
dengu
case
account
america
howev
reliabl
biomark
dengu
sever
specif
antivir
therapi
licens
antidengu
vaccin
avail
world
health
organ
guzman
et
al
simmon
et
al
world
health
organ
classif
dengu
dengu
fever
df
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
proven
use
year
still
revis
classif
propos
recent
intern
multicent
studi
dengu
without
warn
sign
dengu
warn
sign
sever
dengu
world
health
organ
alexand
et
al
pathogenesi
dengu
multifactori
fulli
understood
thu
far
complex
interplay
among
viral
immunolog
host
factor
demonstr
interplay
includ
immun
enhanc
secondari
dengu
infect
increas
uptak
complex
monocyt
macrophag
klik
et
al
studi
also
shown
involv
storm
cytokin
solubl
mediat
releas
immun
cell
braga
et
al
bozza
et
al
hyperactiv
lymphocyt
rothman
influenc
infect
viral
serotyp
balmaseda
et
al
comorbid
limonta
et
al
genet
background
sierra
et
al
also
associ
pathophysiolog
viral
diseas
apoptot
cell
death
propos
play
role
dengu
pathophysiolog
previou
studi
dengu
infect
shown
apoptosi
lymphocyt
mongkolsapaya
et
al
myint
et
al
monocyt
et
al
levi
et
al
peripher
blood
mononuclear
cell
pbmc
jaiyen
et
al
apoptot
cell
also
found
varieti
tissu
fatal
dengu
case
huerr
et
al
limonta
et
al
caspas
proteas
essenti
cellular
protein
involv
apoptosi
program
cell
death
caspas
activ
inhibit
inhibitor
apoptosi
protein
iap
hotchkiss
et
al
survivin
consid
fundament
iap
play
role
tumorigenesi
inflamm
altieri
howev
role
survivin
poorli
studi
viral
diseas
zhu
et
al
bokarewa
et
al
extrins
death
receptor
pathway
one
two
apoptot
pathway
mediat
transmembran
receptor
extrins
pathway
activ
ligand
member
tumor
necrosi
factor
tnf
superfamili
ligand
trail
fa
ligand
fasl
also
known
bind
death
receptor
ligand
display
proapoptot
function
form
solubl
form
locksley
et
al
galluzzi
et
al
although
extens
studi
dengu
cardier
et
al
chen
et
al
levi
et
al
vitro
action
trail
describ
wark
et
al
data
appear
avail
interplay
among
circul
pro
antiapoptot
mediat
dengu
patient
furthermor
knowledg
revis
classif
dengu
world
health
organ
use
studi
apoptosi
dengu
case
present
work
apoptot
mediat
measur
plasma
pbmc
lysat
brazilian
patient
dengu
first
time
apoptot
protein
measur
patient
classif
dengu
revis
three
plasma
molecul
evalu
fasl
trail
fundament
apoptosi
induc
protein
studi
plasma
survivin
pbmc
lysat
protein
iap
data
suggest
trail
could
involv
apoptosi
induct
blood
lymphocyt
could
also
contribut
antivir
respons
convers
iap
may
particip
apoptosi
protect
blood
leukocyt
fasl
may
display
role
dengu
pathophysiolog
especi
fatal
case
dengu
venou
blood
sampl
obtain
febril
case
dengu
outbreak
southwest
brazil
case
diagnosi
dengu
confirm
patient
assist
centro
de
em
dengu
campo
do
goytacaz
rio
de
janeiro
state
hospit
professora
esterina
corsini
universidad
feder
mato
grosso
sul
mato
grosso
sul
state
pbmc
plasma
collect
health
care
facil
transport
liquid
nitrogen
viral
immunolog
laboratori
oswaldo
cruz
institut
store
liquid
nitrogen
use
pbmc
plasma
sampl
healthi
adult
collect
control
inclus
criteria
control
absenc
fever
histori
preced
three
month
absenc
chronic
diseas
neg
igm
elisa
panbio
diagnost
brisban
australia
studi
protocol
approv
institut
review
board
oswaldo
cruz
foundat
fiocruz
number
ministri
health
brazil
recogn
brazilian
nation
ethic
committe
institut
review
board
brazilian
hospit
involv
studi
enrol
studi
particip
patient
age
requir
parentsleg
guardian
consent
control
subject
condit
obtain
appropri
written
inform
consent
case
consid
posit
dengu
diagnost
assay
met
one
follow
criteria
igm
detect
acut
sampl
captur
igm
immunosorb
assay
elisa
panbio
diagnost
denv
rna
detect
serum
assay
describ
elsewher
lanciotti
et
al
denv
isol
acut
sampl
inocul
onto
aed
albopictu
cell
subsequ
immunoflouresc
detect
viral
antigen
describ
previous
igarashi
detect
protein
use
antigen
strip
hercul
ca
acut
serum
follow
manufactur
instruct
new
dengu
classif
criteria
consist
dengu
without
warn
sign
dengu
warn
sign
sever
dengu
use
case
dengu
without
warn
sign
compris
fever
least
two
follow
nausea
vomit
rash
ach
pain
posit
tourniquet
test
leucopenia
dengu
warn
sign
includ
dengu
patient
follow
warn
sign
abdomin
pain
tender
persist
vomit
clinic
fluid
accumul
mucos
bleed
lethargi
restless
liver
enlarg
cm
increas
hematocrit
concurr
rapid
decreas
platelet
count
sever
dengu
includ
least
one
follow
sever
plasma
leakag
lead
shock
fluid
accumul
respiratori
distress
sever
bleed
evalu
clinician
sever
involv
liver
aspart
aminotransferas
ast
alanin
transferas
alt
u
central
nervou
system
impair
conscious
sever
involv
heart
organ
world
health
organ
upon
enrol
consult
hospit
standard
form
data
collect
complet
studi
clinician
experienc
dengu
form
includ
demograph
inform
vital
sign
physic
examin
complet
blood
count
liver
enzym
valu
alt
alanin
transaminas
ast
aspart
transaminas
find
ultrasound
ml
peripher
venou
blood
collect
anticoagul
tube
patient
control
subject
pbmc
separ
blood
sampl
use
procedur
gml
st
loui
mo
centrifug
min
pbmc
layer
wash
twice
rpmi
medium
viabil
pbmc
greater
trypan
blue
exclus
approxim
pbmc
resuspend
ml
freez
solut
consist
inactiv
fb
invitrogen
carlsbad
ca
plu
dmso
store
hr
transfer
liquid
nitrogen
aliquot
cryopreserv
later
studi
lymphocyt
subpopul
cell
monocyt
enumer
five
flow
cytometri
method
use
follow
monoclon
antibodi
allophycocyanin
cyanin
dye
apc
conjug
biolegend
san
diego
ca
phycoerythrin
cyanin
dye
pe
conjug
bd
bioscienc
san
jose
ca
phycoerythrin
cyanin
dye
pe
conjug
southern
biotech
birmingham
al
appropri
control
antibodi
use
discrimin
posit
neg
populationssubset
subpopul
subset
leukocyt
determin
stain
cell
peripher
blood
appropri
combin
monoclon
antibodi
pbmc
suspend
pb
cell
incub
ice
min
dark
monoclon
antibodi
wash
twice
pb
fix
paraformaldehyd
fix
cell
kept
dark
use
minimum
cell
gate
event
acquir
use
cyan
flow
cytomet
dako
glostrup
denmark
analysi
perform
use
flow
jo
softwar
tree
star
ashland
plasma
concentr
proapoptot
protein
fasl
trail
antiapoptot
survivin
measur
elisa
quantikin
r
system
minneapoli
mn
accord
manufactur
instruct
concentr
plasma
determin
elisa
pepro
tech
inc
rocki
hill
nj
follow
manufactur
instruct
analysi
cellular
inhibitor
apoptosi
protein
cellular
inhibitor
apoptosi
protein
inhibitor
apoptosi
protein
xiap
express
profil
perform
lysat
pbmc
obtain
dengu
patient
control
follow
manufactur
instruct
human
apoptosi
array
kit
proteom
array
r
system
apoptosi
array
data
develop
film
quantifi
use
quantiti
one
imag
analysi
softwar
version
templat
analyz
pixel
densiti
spot
array
creat
background
valu
subtract
comparison
correspond
signal
differ
array
carri
determin
rel
chang
iap
level
patient
control
sampl
data
enter
analyz
use
epidata
softwar
version
odens
denmark
differ
comparison
analysi
carri
spearman
test
use
prism
softwar
graphpad
san
diego
ca
test
appli
p
consid
signific
patient
dengu
control
individu
includ
protein
analysi
tabl
mean
age
patient
control
subject
year
old
femalemal
gender
distribut
patient
patient
infect
denv
recruit
first
eleventh
day
fever
onset
dengu
infect
caus
patient
dengu
classifi
dengu
without
warn
sign
dengu
warn
sign
sever
dengu
follow
dengu
classif
revis
world
health
organ
one
fatal
case
record
sever
dengu
group
patient
sever
dengu
commonli
bleed
vascular
leakag
manifest
hypotens
rest
studi
dengu
patient
tabl
hematocrit
valu
increas
diseas
sever
decreas
platelet
count
significantli
relat
sever
patient
group
show
valu
control
subject
valu
liver
enzym
ast
alt
increas
sever
fold
patient
sever
dengu
increas
statist
signific
p
total
number
leukocyt
three
cell
subpopul
increas
diseas
sever
tabl
ii
howev
frequenc
absolut
number
leukocyt
differ
significantli
among
three
group
patient
dengu
particular
lymphocyt
count
significantli
higher
control
group
compar
dengu
without
warn
sign
group
shown
figur
significantli
elev
level
fasl
found
patient
dengu
without
warn
sign
pgml
patient
sever
dengu
pgml
control
subject
pgml
remark
elev
valu
fasl
record
singl
fatal
dengu
case
pgml
day
death
addit
trail
level
patient
dengu
without
warn
sign
pgml
statist
elev
compar
patient
sever
dengu
pgml
control
individu
pgml
fig
trail
apoptosi
mediat
differenti
patient
dengu
warn
sign
pgml
sever
dengu
survivin
level
plasma
dengu
patient
show
variabl
name
result
show
decreas
survivin
level
fig
patient
dengu
warn
sign
pgml
compar
control
individu
pgml
patient
sever
dengu
pgml
signific
differ
found
level
among
dengu
patient
studi
fig
howev
cytokin
significantli
elev
dengu
patient
without
warn
sign
control
subject
trail
level
platelet
count
posit
associ
dengu
patient
tabl
iii
neg
relationship
found
trail
level
total
lymphocyt
neg
correl
also
occur
subpopul
lymphocyt
contrast
trail
survivin
level
posit
relat
peripher
leukocyt
lymphocyt
count
especi
monocyt
count
relationship
found
survivin
level
platelet
count
fasl
correl
posit
trail
r
p
data
shown
preliminari
profil
data
iap
famili
member
xiap
evalu
pbmc
lysat
control
subject
n
patient
dengu
n
two
patient
dengu
without
warn
sign
four
sever
dengu
trend
increas
level
express
xiap
detect
patient
sever
dengu
patient
dengu
without
warn
sign
control
subject
fig
trend
statist
signific
present
observ
studi
level
mediat
measur
plasma
pbmc
lysat
sampl
brazilian
patient
sever
dengu
patient
infect
either
goal
explor
interplay
proapoptot
antiapoptot
mechan
dengu
diseas
find
sever
dengu
patient
hypotens
hemorrhag
vascular
leakag
manifest
decreas
platelet
count
increas
valu
hepat
enzym
agreement
previou
studi
use
dengu
clinic
classif
revis
barniol
et
al
narvaez
et
al
et
al
hand
sever
cell
line
infect
denv
fasfasl
mechan
involv
cell
death
liew
chow
limjindaporn
et
al
et
al
liao
et
al
modul
immun
respons
apoptosi
dengu
report
previous
thai
children
show
higher
level
plasma
solubl
fa
dhf
df
myint
et
al
howev
present
studi
perform
mainli
adult
popul
measur
circul
mediat
fasl
therefor
first
report
studi
circul
fasl
molecul
dengu
studi
fasl
valu
patient
dengu
without
warn
sign
elev
compar
patient
sever
dengu
control
subject
howev
premortem
detect
fasl
fatal
dengu
case
show
highest
fasl
valu
measur
studi
like
highest
valu
due
plasma
sampl
obtain
day
death
dengu
fatal
studi
understand
elev
proapoptot
mediat
critic
phase
dengu
relat
fatal
outcom
explor
probabl
mechan
action
involv
present
studi
elev
trail
level
observ
patient
dengu
without
warn
sign
compar
sever
dengu
control
subject
addit
trail
level
discrimin
patient
dengu
warn
sign
patient
sever
dengu
previou
vitro
studi
demonstr
increas
trail
product
denv
infect
varieti
human
primari
cell
includ
umbil
vein
endotheli
cell
wark
et
al
muscl
satellit
cell
wark
et
al
dendrit
cell
monocyt
b
cell
wark
et
al
becerra
et
al
bala
et
al
wong
et
al
human
primari
cell
demonstr
apoptot
activ
trail
convers
antivir
action
trail
shown
recombin
trail
pretreat
monocyt
dendrit
cell
wark
et
al
anoth
studi
show
serum
elev
trail
venezuelan
dengu
patient
compar
febril
patient
without
dengu
control
subject
howev
previou
studi
involv
two
dhf
case
analyz
dengu
sever
becerra
et
al
find
present
work
use
revis
dengu
classif
suggest
antivir
action
trail
shown
previous
cell
cultur
wark
et
al
may
also
occur
vivo
henc
like
increas
sever
dengu
patient
lack
elev
trail
product
previou
studi
wark
et
al
trail
inhibit
denv
infect
dendrit
cell
mechan
mechan
link
type
ifn
signal
pathway
find
suggest
antivir
action
trail
could
mediat
known
novel
cellular
protein
induc
trail
trail
hypothesi
trail
antivir
action
direct
dengu
infect
support
recent
find
shrestha
et
al
author
demonstr
trail
secret
cell
provid
antivir
signal
neuron
infect
west
nile
viru
flaviviru
close
relat
denv
effect
studi
central
nervou
system
mous
model
primari
cultur
mous
cortic
neuron
work
suggest
trail
produc
cell
necessari
suffici
confer
antivir
effect
effect
requir
addit
secret
cytokin
andor
cytolyt
activ
cell
recent
work
research
group
gandini
et
al
found
denv
infect
activ
plasmacytoid
dendrit
cell
pbmc
healthi
donor
lead
subsequ
express
trail
cell
membran
research
also
found
dengu
patient
activ
plasmacytoid
dendrit
cell
membran
trail
associ
less
sever
dengu
report
also
confirm
vitro
antivir
action
recombin
trail
monocyt
infect
denv
trail
product
plasmacytoid
dendrit
cell
associ
product
previou
studi
shown
trail
regul
megakaryocytopoiesi
zauli
secchiero
promot
matur
megakaryoblast
platelet
melloni
et
al
addit
shown
vitro
activ
platelet
releas
trail
crist
et
al
howev
studi
need
determin
whether
trail
relat
platelet
increas
trail
releas
platelet
dengu
infect
invers
correl
among
level
proapoptot
trail
count
lymphocyt
subpopul
support
hypothesi
trail
relat
lymphocyt
cell
death
similar
phenomenon
report
patient
infect
hiv
cummin
badley
respiratori
syncyti
viru
roe
et
al
sar
coronaviru
law
et
al
measl
viru
okada
et
al
primat
model
ebola
viru
diseas
hensley
et
al
therefor
apoptosi
might
contribut
factor
modul
number
lymphocyt
dengu
infect
document
previous
myint
et
al
trail
express
increas
primari
hepatocyt
cell
infect
dengu
suksanpaisan
et
al
howev
signific
trail
action
hepat
cell
remain
unclear
retract
work
matsuda
et
al
current
investig
liver
cell
studi
howev
rule
express
trail
liver
cell
infect
denv
releas
circul
clearanc
infect
liver
cell
present
studi
plasma
level
significantli
higher
dengu
patient
without
warn
sign
compar
control
differ
found
level
among
three
group
dengu
patient
studi
although
one
studi
cytokin
dengu
infect
associ
diseas
sever
still
debat
one
hand
studi
found
associ
dhf
hober
et
al
braga
et
al
levi
et
al
hand
studi
found
associ
laur
et
al
bozza
et
al
hoang
et
al
priyadarshini
et
al
discrep
detect
dengu
studi
might
relat
sever
factor
previou
report
dengu
patient
found
differ
product
associ
genet
polymorph
et
al
vejbaesya
et
al
perez
et
al
addit
vitro
induct
azizan
et
al
highest
plasma
level
occur
sixth
day
dengu
diseas
hober
et
al
level
elev
singl
fatal
case
dengu
studi
find
agreement
previou
work
show
differ
level
among
fatal
case
dengu
survivor
df
dhf
chen
et
al
iap
particip
multipl
intracellular
pathway
compris
cell
death
surviv
altieri
exampl
survivin
express
relat
vitro
lymphocyt
divis
clonal
expans
song
et
al
hand
previou
studi
shown
associ
survivin
circul
induct
adhes
molecul
surfac
blood
leukocyt
mera
et
al
presenc
antiapoptosi
pathway
protein
dengu
infect
may
counteract
role
proapoptosi
signal
molecul
antiapoptot
protein
survivin
studi
dengu
infect
first
time
present
studi
molecul
show
variabl
level
reduc
level
patient
dengu
without
warn
sign
compar
control
subject
patient
sever
dengu
survivin
posit
correl
count
leukocyt
lymphocyt
monocyt
dengu
patient
studi
although
work
verifi
experiment
exocytosi
survivin
extracellular
action
survivin
white
blood
cell
correl
result
suggest
survivin
may
associ
prolifer
leukocyt
special
monocyt
dengu
addit
elev
survivin
level
may
provid
protect
apoptosi
immunolog
blood
cell
circul
dengu
patient
studi
iap
known
abil
regul
caspas
cell
death
silk
meier
although
preliminari
present
studi
show
express
iap
famili
member
pbmc
markedli
higher
patient
sever
dengu
patient
dengu
without
warn
sign
control
subject
result
suggest
iap
may
involv
apoptosi
inhibit
pbmc
howev
clear
whether
antiapoptot
effect
iap
might
counteract
probabl
induct
apoptosi
trail
circul
lymphocyt
thu
antiapoptot
mechan
may
interact
real
impact
need
investig
even
though
current
studi
novel
find
protein
relat
apoptosi
dengu
patient
still
sever
limit
instanc
patient
stratifi
day
infect
could
explain
larg
standard
deviat
mean
valu
lymphocyt
count
measur
number
lymphocyt
plasma
concentr
apoptot
protein
daili
would
accur
way
compar
group
dengu
patient
howev
higher
count
total
lymphocyt
subpopul
patient
sever
dengu
patient
without
sever
clinic
form
dengu
agreement
previou
studi
kadhiravan
et
al
et
al
addit
lack
data
viremia
immun
statu
may
limit
interpret
preliminari
result
studi
inclus
healthi
subject
febril
patient
without
dengu
control
group
may
prefer
addit
genet
polymorph
might
affect
circul
level
apoptot
mediat
previous
shown
studi
trail
korner
et
al
fasl
nasi
et
al
survivin
borg
bdo
et
al
infecti
condit
conclus
fasl
may
exhibit
function
differ
clinic
form
dengu
diseas
fatal
dengu
hypothes
trail
role
induc
apoptosi
lymphocyt
dengu
patient
survivin
seem
like
promot
surviv
prolifer
blood
leukocyt
wherea
iap
famili
member
may
involv
antiapoptot
pathway
pbmc
dengu
research
done
character
complex
interplay
pro
antiapoptot
mediat
differ
phase
dengu
diseas
identifi
implic
dengu
sever
